Cargando…
KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
Liver cancer is thought as the most common human malignancy worldwide, and hepatocellular carcinoma (HCC) accounts for nearly 90% liver cancer. Due to its poor early diagnosis and limited treatment, HCC has therefore become the most lethal malignant cancers in the world. Recently, molecular targeted...
Autores principales: | Sun, Yue-Feng, Wu, Hong-Li, Shi, Rui-Fang, Chen, Lin, Meng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157793/ https://www.ncbi.nlm.nih.gov/pubmed/32318326 http://dx.doi.org/10.1155/2020/6403012 |
Ejemplares similares
-
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers
por: Hu, Zhan-Dong, et al.
Publicado: (2021) -
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo
por: Gao, Zhenya, et al.
Publicado: (2021) -
[Retracted] KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo
por: Gao, Zhenya, et al.
Publicado: (2023) -
KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway
por: Zhao, Hongda, et al.
Publicado: (2019) -
Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation
por: Huang, Xiaodong, et al.
Publicado: (2013)